Recent Updates
Recently added Catalysts
ANAB Positive Sentiment Score: 70/100

Anaptys to Participate at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference

Monday, May 4, 2026 1 min read
Key Takeaway: AnaptysBio, Inc. will have its CEO, Daniel Faga, participate in a fireside chat at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference on May 6, 2026. The discussion aims to highlight the company's financial collaborations, particularly with GSK and Vanda. This event is an opportunity for investors to gain insights into AnaptysBio's strategies and future directions.

Market Sentiment Analysis

POSITIVE FACTORS

  • AnaptysBio is actively engaging with investors.
  • Participation in a prominent virtual conference highlights company visibility.
  • Focus on financial collaborations suggests a strategic approach to revenue.

Full Press Release Details

SAN DIEGO, May 04, 2026 (GLOBE NEWSWIRE) -- AnaptysBio, Inc. (Nasdaq: ANAB), a company focused on managing the financial collaborations forJemperliwith GSK and imsidolimab with Vanda, today announced that Daniel Faga, president and chief executive officer of Anaptys, is scheduled to participate in a fireside chat at the H.C. Wainwright 2nd Annual Royalty Company Virtual Conference on Wednesday, May 6, 2026. The fireside chat is scheduled to begin at 1:30pm ET.
To register for the conference, please visithttps://hcwevents.com/royalty-company-conference.
About AnaptysAnaptys manages the financial collaborations forJemperliwith GSK and imsidolimab with Vanda, with a focus on protecting and returning the value of its royalties to shareholders. To learn more, visitwww.AnaptysBio.comor follow us onLinkedIn.Contact:Anaptys Investor Relationsinvestors@anaptysbio.com

Frequently Asked Questions

When is AnaptysBio's participation in the conference?

AnaptysBio will participate in the conference on May 6, 2026.

Who will represent AnaptysBio at the conference?

Daniel Faga, the CEO of AnaptysBio, will represent the company.

What is the focus of AnaptysBio's financial collaborations?

AnaptysBio focuses on managing collaborations for Jemperli with GSK and imsidolimab with Vanda.

How can I register for the conference?

You can register for the conference at the H.C. Wainwright events website.

Tags: ANAB Viatris Investor Conferences Healthcare AnaptysBio H.C. Wainwright Daniel Faga Jemperli imsidolimab
Last updated: May 4, 2026